2 completed, 1 withdrawn. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
Follow Steminent Biotherapeutics Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Study of Stemchymal® in Acute Liver Failure Stemchymal® - Stem Cells, Adult Stem Cells | Phase 1 | Withdrawn | Steminent Biotherapeutics Inc. | 2018-10-01 | 2022-10-28 | |
| Efficacy and Safety Study of Stemchymal® in Polyglutamine Spinocerebellar Ataxia Stemchymal®, Excipients - Cerebellar Ataxia | Phase 2 | Completed | Steminent Biotherapeutics Inc. | 56 | 2015-09-01 | 2022-10-27 |
| Mesenchymal Stem Cell Treatment for Primary Osteoarthritis Knee Adipose-Derived Mesenchymal Stem Cells - Osteoarthritis Knee | Phase 1 | Completed | Steminent Biotherapeutics Inc. | 4 | 2015-06-01 | 2022-10-28 |
Acute-On-Chronic Liver Failure (1) · Cerebellar Ataxia (1) · Liver Failure, Acute (1) · Osteoarthritis, Knee (1) · Spinocerebellar Ataxias (1)
Excipients (1)
Taiwan (3)